Emergency Use Authorization for TURKOVAC
"Emergency Use Authorization for the first domestic inactivated COVID-19 vaccine-named TURKOVAC, developed with the support of Health Institutes of Turkey (TÜSEB), is granted after the scientific investigation of the Ministry of Health of the Republic of Turkey - Turkish Medicines and Medical Devices Agency (TİTCK)."
Application for the Emergency Use Authorization for TURKOVAC, whose Phase-III studies were launched on June 22 and are ongoing in 41 centres now, was submitted to Turkish Medicines and Medical Devices Agency on November 25th, 2021. Emergency Use Authorization Evaluation Committee has decided that TURKOVAC is granted Emergency Use Authorization, assessing scientific data in accordance with international pharmacy standards. Emergency Use Authorization is a permission mechanism, granted exceptionally by the authorized institution for medical products that can be used to respond to public health threats of communicable diseases until regular license approval is provided by the responsible institution.
“TURKOVAC” made history as the first domestic COVID-19 vaccine, which was developed locally and by Turkish scientists in Turkey at every stage from R&D to manufacturing and that is granted with Emergency Use Authorization.